TAGAMET HB LAUNCH PLAN INCLUDES MAILINGS TO 460,000 HEALTH PROFESSIONALS
This article was originally published in The Tan Sheet
Executive Summary
TAGAMET HB LAUNCH PLAN INCLUDES MAILINGS TO 460,000 HEALTH PROFESSIONALS to announce the availability of the OTC cimetidine product and to provide information on the drug's labeled indications, dosing, warnings and precautions, SmithKline Beecham Consumer Healthcare Products President-North America Jack Ziegler told a joint meeting of FDA's Nonprescription Drugs and Gastrointestinal Drugs Advisory Committees on July 27. "Immediately upon approval" of Tagamet HB, mailgrams will be sent to 300,000 physicians, 110,000 pharmacists and 50,000 allied health professionals, Ziegler said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning